Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human
Vaxinano has raised $6.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2024.
Vaxinano's investors include Bpifrance, TCD Capital (ex TheClubDeal), Nord France Amorcage, WiSEED, Captech Sante.
Vaxinano is headquartered in Lille, France.
Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human
Vaxinano is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vaxinano — Funding & Investors." VCBacked, October 29, 2024, https://www.vcbacked.co/company/vaxinano. Accessed November 14, 2026.
VCBacked. (2024). Vaxinano — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/vaxinano
{{cite web |title=Vaxinano — Funding & Investors |url=https://www.vcbacked.co/company/vaxinano |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Vaxinano? Request a listing update